Chindex International, Inc. Adopts Voluntary Executive Compensation Restrictions

Thursday, December 18, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

BETHESDA, Md., Dec. 17 Chindex International, Inc.(Nasdaq: CHDX), a leading independent American provider of western healthcareproducts and services in the People's Republic of China, today announced thatits senior executives have voluntarily offered not to accept any increases intheir respective current salary, bonus, equity awards or other compensationentitlements for fiscal 2009. This unsolicited offer has been accepted by theCompensation Committee of the Board of Directors.

Roberta Lipson, President and CEO of Chindex, commented, "Our decision issolely to demonstrate and effect our commitment to cost control and is notrelated to the operations of the Company. We remain enthusiastic about ourlong-term market opportunities and we feel strongly that, given the globalfinancial crises, we should enforce stringent cost control whenever possible.Today's action also reflects the long-term vision and dedication to Chindexthat all of our senior executives share."

About Chindex International, Inc.

Chindex is an American healthcare company that provides healthcareservices and supplies medical capital equipment, instrumentation and productsto the Chinese marketplace, including Hong Kong. Healthcare services areprovided through the operations of its United Family Hospitals and Clinics, anetwork of private primary care hospitals and affiliated ambulatory clinics inChina. The Company's hospital network currently operates in the Beijing,Shanghai, Guangzhou and Wuxi. The Company sells medical products manufacturedby various major multinational companies, including Siemens AG and IntuitiveSurgical, for which the Company is the exclusive distribution partner for thesale and servicing of color ultrasound systems and surgical robotic systemsrespectively. It also arranges financing packages for the supply of medicalproducts to hospitals in China utilizing the export loan and loan guaranteeprograms of both the U.S. Export-Import Bank and the German KfW DevelopmentBank. With twenty-seven years of experience, approximately 1,200 employees,and operations in China, Hong Kong, the United States and Germany, theCompany's strategy is to expand its cross-cultural reach by providing leadingedge healthcare technologies, quality products and services to Greater China'sprofessional communities. Further company information may be found at theCompany's websites, and .

Safe Harbor Statement

Statements made in this press release relating to plans, strategies,objectives, economic performance and trends and other statements that are notdescriptions of historical facts may be forward-looking statements within themeaning of Section 27A of the Securities Act of 1933, as amended (the"Securities Act"), and Section 21E of the Securities Exchange Act of 1934, asamended (the "Exchange Act"). Forward-looking information is inherentlysubject to risks and uncertainties, and actual results could differ materiallyfrom those currently anticipated due to a number of factors, which include,but are not limited to, the factors set forth under the heading "Risk Factors"in our annual report on Form 10-K for the year ended March 31, 2008, updatesand additions to those "Risk Factors" in our interim reports on Form 10-Q,Forms 8-K and in other documents filed by us with the Securities and ExchangeCommission from time to time. Forward-looking statements may be identified byterms such as "may", "will", "should", "could", "expects", "plans", "intends","anticipates", "believes", "estimates", "predicts", "forecasts", "potential",or "continue" or similar terms or the negative of these terMs. Although webelieve that the expectations reflected in the forward-looking statements arereasonable, we cannot guarantee future results, levels of activity,performance or achievements. We have no obligation to update these forward-looking statements.For more information, please contact: Integrated Corporate Relations Ashley M. Ammon and Jeanne Dellicarri Tel: +1-203-682-8200

SOURCE Chindex International, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store